Immunic Inc. buy Brookline Capital Management
Start price
05.04.24
/
50%
€1.27
Target price
05.04.25
€9.25
Performance (%)
-4.90%
Price
06.09.24
€1.20
Summary
This prediction is currently active. With a performance of -4.90%, the BUY prediction by Brookline_Capital_Ma is trending in the wrong direction. This prediction currently runs until 05.04.25. The prediction end date can be changed by Brookline_Capital_Ma at any time. Brookline_Capital_Ma has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Immunic Inc. | -12.181% | -12.181% |
iShares Core DAX® | -3.429% | 5.085% |
iShares Nasdaq 100 | -6.121% | 0.593% |
iShares Nikkei 225® | -7.364% | 5.479% |
iShares S&P 500 | -4.366% | 2.019% |
Comments by Brookline_Capital_Ma for this prediction
In the thread Immunic Inc. diskutieren
Immunic, Inc. (NASDAQ: IMUX) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $10.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat